2031年までのベータグルカン市場レポート

レポートナンバー　0000030292

健康・健康食品・特定保健用食品

2031年までのベータグルカン市場レポート

Visiongain

Beta Glucan Market Report to 2031

発刊日 2021/09/01

言語英語

体裁PDF/231ページ

ライセンス/価格231ページ

0000030292

Single - 1 Year License	3,499GBP
(Team License - Up to 6 Users) - 1 Year License	3,899GBP
Site	4,999GBP
Enterprise	6,999GBP

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス（ライセンス期間1年、ユーザー数5人）をご検討ください。
※詳しくはお問い合わせください。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

ソース別予測（穀物、海藻、酵母、キノコ）、カテゴリー別（可溶性、不溶性）、最終用途業種別（食品および飲料、パーソナルケア、ヘルスケア、動物飼料）、純度別（20％未満、20％〜 30％、30％から50％、50％から70％、70％以上）、に加え、主要なベータグルカンメーカーのプロファイル、地域＆主要国市場の分析、プラスCOVID-19 回復シナリオ

ベータグルカン市場-動向、研究開発の進捗状況、売上予測
ベータグルカン市場はどこへ向かっているのでしょうか。このレポートは、今後2030年までの収益の流れを示し、データ、動向、事業機会、事業の将来見通しを明らかにします。

一歩先を行くために：
655ページのレポートに822の表と825のグラフを掲載。読み進めるうちにこの業界で最も収益性の高い分野と市場の将来見通しが明らかになります。世界市場全体と地域別の各レベルで売上を予測することが可能です。成長を続ける世界のベータグルカン市場には多くのビジネスチャンスが残っています。

レポート詳細

3. Beta Glucan Market Overview
3.1. Global Beta Glucan Market Size and Forecast by Region
3.2. Global Beta Glucan Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing Healthcare Expenditure
3.3.1.2. Growing Availability of Raw Material for Beta Glucan
3.3.1.3. Growing Mushroom Cultivation in Asia Pacific
3.3.2. Market Restraints/Challenges
3.3.2.1. Strict Government Regulations Concerning Beta Glucan
3.3.2.2. High Extraction Costs
3.3.3. Opportunities
3.3.3.1. Growing Application base for Beta Glucan in Emerging Nations
3.3.4. Global Beta Glucan Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry

4. Global Beta Glucan Market Analysis and Forecast 2021-2031, by Purity (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Below 20%
4.1.2. 20% to 30%
4.1.3. 30% to 50%
4.1.4. 50% to 70%
4.1.5. Above 70%

5. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by Category (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Soluble
5.1.2. In-soluble

6. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by Source (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Cereal
6.1.1.1. High Production of Cereals Driving Market Growth for Beta Glucan
6.1.2. Seaweed
6.1.2.1. Low Molecular Complexity Associated with Extracting Beta Glucan from Seaweed
6.1.3. Yeast
6.1.3.1. High Availability of Yeast
6.1.4. Mushroom
6.1.4.1. Growing Mushroom Cultivation in Asia Pacific

7. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by End-use Industries (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Food & Beverage
7.1.1.1. Growing Demand for Functional Food& Beverages in Emerging Nations
7.1.2. Personal Care
7.1.2.1. Promising Market Growth Personal Care Products in Emerging Nations
7.1.3. Healthcare
7.1.3.1. Growing Healthcare Expenditure
7.1.4. Animal Feed
7.1.4.1. Growing Livestock Production

8. North America Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. North America Beta Glucan Market Size and Forecast by Purity
8.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
8.3. North America Beta Glucan Market Size and Forecast by Category
8.3.1. Soluble Submarket to Grow at Fastest Rate
8.4. North America Beta Glucan Market Size and Forecast by Source
8.4.1. Cereals Submarket to Grow at Fastest Rate
8.5. North America Beta Glucan Market Size and Forecast by End-use Industries
8.5.1. Food & Beverages Submarket to Grow at Fastest Rate
8.6. U.S. Beta Glucan Market
8.7. Canada Beta Glucan Market

9. Europe Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Europe Beta Glucan Market Size and Forecast by Purity
9.2.1. 30% to 50% Submarket Expected to Grow at Fastest Rate
9.3. Europe Beta Glucan Market Size and Forecast by Category
9.3.1. Soluble Submarket to Grow at Fastest Rate
9.4. Europe Beta Glucan Market Size and Forecast by Source
9.4.1. Yeast Submarket to Grow at Fastest Rate
9.5. Europe Beta Glucan Market Size and Forecast by End-use Industries
9.5.1. Food & Beverages Submarket to Grow at Fastest Rate
9.6. UK Beta Glucan Market
9.7. Germany Beta Glucan Market
9.8. France Beta Glucan Market
9.9. Italy Beta Glucan Market
9.10. Spain Beta Glucan Market
9.11. Russia Beta Glucan Market
9.12. Netherlands Beta Glucan Market
9.13. Rest of Europe Beta Glucan Market

10. Asia Pacific Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Asia Pacific Beta Glucan Market Size and Forecast by Purity
10.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
10.3. Asia Pacific Beta Glucan Market Size and Forecast by Category
10.3.1. Insoluble Submarket to Grow at Fastest Rate
10.4. Asia Pacific Beta Glucan Market Size and Forecast by Source
10.4.1. Mushroom Submarket to Grow at Fastest Rate
10.5. Asia Pacific Beta Glucan Market Size and Forecast by End-use Industries
10.5.1. Personal Care Submarket to Grow at Fastest Rate
10.6. China Beta Glucan Market
10.7. India Beta Glucan Market
10.8. Japan Beta Glucan Market
10.9. Australia Beta Glucan Market
10.10. South Korea Beta Glucan Market
10.11. Southeast Asia Beta Glucan Market
10.12. Rest of Asia Pacific Beta Glucan Market

11. Latin America Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Latin America Beta Glucan Market Size and Forecast by Purity
11.2.1. Below 20% Submarket Expected to Grow at Fastest Rate
11.3. Latin America Beta Glucan Market Size and Forecast by Category
11.3.1. Soluble Submarket to Grow at Fastest Rate
11.4. Latin America Beta Glucan Market Size and Forecast by Source
11.4.1. Cereals Supplement Submarket to Grow at Fastest Rate
11.5. Latin America Beta Glucan Market Size and Forecast by End-use Industries
11.5.1. Healthcare Submarket to Grow at Fastest Rate
11.5.2. Brazil Beta Glucan Market
11.5.3. Colombia Beta Glucan Market
11.5.4. Argentina Beta Glucan Market
11.5.5. Mexico Beta Glucan Market
11.5.6. Rest of Latin America Beta Glucan Market

12. Middle East & Africa Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Middle East & Africa Beta Glucan Market Size and Forecast by Purity
12.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
12.3. Middle East & Africa Beta Glucan Market Size and Forecast by Category
12.3.1. Soluble Submarket to Grow at Fastest Rate
12.4. Middle East & Africa Beta Glucan Market Size and Forecast by Source
12.4.1. Cereals Submarket to Grow at Fastest Rate
12.5. Middle East & Africa Beta Glucan Market Size and Forecast by End-use Industries
12.5.1. Food & Beverage Submarket to Grow at Fastest Rate
12.5.2. Turkey Beta Glucan Market
12.5.3. Saudi Arabia Beta Glucan Market
12.5.4. South Africa Beta Glucan Market
12.5.5. UAE Beta Glucan Market
12.5.6. Egypt Beta Glucan Market
12.5.7. Rest of Middle East & Africa Beta Glucan Market

13. Companies in the Beta Glucan Market
13.1. Cargill Inc.
13.1.1. Company Snapshot
13.1.2. Company Overview
13.1.3. Financial Performance (2015-2019)
13.1.3.1. Net Revenue
13.1.3.2. Gross Profit
13.1.3.3. Geographical Revenue, 2019
13.1.4. Product Offerings
13.1.5. Recent Initiatives (2018-2020)
13.2. Tate & Lyle Plc
13.2.1. Company Snapshot
13.2.2. Company Overview
13.2.3. Financial Performance (2015-2019)
13.2.3.1. Net Revenue
13.2.3.2. Gross Profit
13.2.3.3. Geographical Revenue, 2019
13.2.4. Product Offerings
13.2.5. Recent Initiatives (2018-2020)
13.3. Kerry Group Plc
13.3.1. Company Snapshot
13.3.2. Company Overview
13.3.3. Financial Performance (2015-2019)
13.3.3.1. Net Revenue
13.3.3.2. Gross Profit
13.3.3.3. Geographical Revenue, 2019
13.3.4. Product Offerings
13.3.5. Recent Initiatives (2018-2020)
13.4. Koninklijke DSM NV
13.4.1. Company Snapshot
13.4.2. Company Overview
13.4.3. Financial Performance (2015-2019)
13.4.3.1. Net Revenue
13.4.3.2. Gross Profit
13.4.3.3. Geographical Revenue, 2019
13.4.4. Product Offerings
13.4.5. Recent Initiatives (2018-2020)
13.5. Frutarom
13.5.1. Company Snapshot
13.5.2. Company Overview
13.5.3. Financial Performance (2015-2019)
13.5.3.1. Net Revenue
13.5.3.2. Gross Profit
13.5.3.3. Geographical Revenue, 2019
13.5.4. Product Offerings
13.5.5. Recent Initiatives (2018-2020)
13.6. Garuda International Inc.
13.6.1. Company Snapshot
13.6.2. Company Overview
13.6.3. Financial Performance (2015-2019)
13.6.3.1. Net Revenue
13.6.3.2. Gross Profit
13.6.3.3. Geographical Revenue, 2019
13.6.4. Product Offerings
13.6.5. Recent Initiatives (2018-2020)
13.7. Ohly
13.7.1. Company Snapshot
13.7.2. Company Overview
13.7.3. Financial Performance (2015-2019)
13.7.3.1. Net Revenue
13.7.3.2. Gross Profit
13.7.3.3. Geographical Revenue, 2019
13.7.4. Product Offerings
13.7.5. Recent Initiatives (2018-2020)
13.8. Milipore Sigma
13.8.1. Company Snapshot
13.8.2. Company Overview
13.8.3. Financial Performance (2015-2019)
13.8.3.1. Net Revenue
13.8.3.2. Gross Profit
13.8.3.3. Geographical Revenue, 2019
13.8.4. Product Offerings
13.8.5. Recent Initiatives (2018-2020)
13.9. Super Beta Glucan
13.9.1. Company Snapshot
13.9.2. Company Overview
13.9.3. Financial Performance (2015-2019)
13.9.3.1. Net Revenue
13.9.3.2. Gross Profit
13.9.3.3. Geographical Revenue, 2019
13.9.4. Product Offerings
13.9.5. Recent Initiatives (2018-2020)
13.10. Alltech Inc.
13.10.1. Company Snapshot
13.10.2. Company Overview
13.10.3. Financial Performance (2015-2019)
13.10.3.1. Net Revenue
13.10.3.2. Gross Profit
13.10.3.3. Geographical Revenue, 2019
13.10.4. Product Offerings
13.10.5. Recent Initiatives (2018-2020)
13.11. Other Notable Players

14. Conclusion

15. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Purity
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation Purity

LIST OF TABLES
Table 1. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Beta Glucan Market Drivers & Restraints 2021
Table 7. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 38. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 313. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 314. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 315. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 316. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 317. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 318. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 319. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 320. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 321. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 322. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 323. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 324. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 325. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 326. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 327. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 328. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 329. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 330. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 331. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 332. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 333. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 334. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 335. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 336. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 337. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 338. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 339. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 340. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 341. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 342. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 343. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 344. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 345. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 346. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 347. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 348. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 349. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 350. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 351. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 352. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 353. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 354. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 355. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 356. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 357. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 358. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 359. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 360. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 361. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 362. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 363. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 364. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 365. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 366. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 367. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 368. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 369. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 370. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 371. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 372. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 373. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 374. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 375. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 376. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 377. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 378. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 379. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 380. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 381. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 382. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 383. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 384. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 385. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 386. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 387. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 388. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 389. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 390. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 391. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 392. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 393. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 394. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 395. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 396. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 397. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 398. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 399. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 400. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 401. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 402. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 403. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 404. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 405. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 406. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 407. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 408. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 409. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 410. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 411. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 412. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 413. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 414. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 415. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 416. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 417. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 418. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 419. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 420. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 421. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 422. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 423. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 424. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 425. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 426. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 427. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 428. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 429. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 430. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 431. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 432. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 433. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 434. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 435. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 436. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 437. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 438. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 439. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 440. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 441. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 442. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 443. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 444. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 445. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 446. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 447. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 448. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 449. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 450. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 451. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 452. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 453. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 454. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 455. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 456. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 457. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 458. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000030292

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。